The clinical utilization of radiation therapy in Korea between 2009 and 2013 |
Kang, Jin-Kyu
(Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences)
Kim, Mi-Sook (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Jang, Won-Il (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Seo, Young Seok (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Kim, Hee Jin (Radiation Medicine Policy Development Center, Korea Institute of Radiological & Medical Sciences) Cho, Chul Koo (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Yoo, Hyung Jun (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Paik, Eun Kyung (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Cha, Yu Jin (Department of Radiation Oncology, Korea Institute of Radiological & Medical Sciences) Song, Hyun Jin (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Kyungpook National University) |
1 | Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 2013;45:1-14. DOI |
2 | Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, Lee JS. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011. Cancer Res Treat 2014;46:109-23. DOI |
3 | Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. DOI |
4 | Oh CM, Won YJ, Jung KW, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2013. Cancer Res Treat 2016;48:436-50. DOI |
5 | Lee TJ, Kim S, Cho HJ, Lee JH. The incidence of thyroid cancer is affected by the characteristics of a healthcare system. J Korean Med Sci 2012;27:1491-8. DOI |
6 | Suh M, Choi KS, Park B, et al. Trends in cancer screening rates among Korean men and women: results of the Korean National Cancer Screening Survey, 2004-2013. Cancer Res Treat 2016;48:1-10. DOI |
7 | Yoo SY, Kim MS, Ji YH, Cho CK, Yang KM, You HJ. Statistics for Department of Radiation Oncology (1999-2001). J Korean Soc Ther Radiol Oncol 2004;22:234-6. |
8 | Kim MS, Ji YH, You SY, Cho CK, Yang KM, Ryu HJ. National statistics of radiation oncology in Korea (2002-2004). J Korean Soc Ther Radiol Oncol 2006;24:77-80. |
9 | Kim MS, Ji YH, You SY, et al. National statistics of radiation oncology in Korea (2005). J Korean Soc Ther Radiol Oncol 2006;24:207-9. |
10 | Ji YH, Kim MS, You SY, You DH, Choi MS, Jung HJ. National statistics of radiation oncology in Korea (2006). J Korean Soc Ther Radiol Oncol 2008;26:131-3. |
11 | Kang JK, Kim MS, Jang WI, et al. The clinical status of radiation therapy in Korea in 2009 and 2013. Cancer Res Treat 2015 Dec 14 [Epub]. http://dx.doi.org/10.4143/crt.2015.370. DOI |
12 | Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 2012;44:11-24. DOI |
13 | Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005;104:1129-37. DOI |
14 | Jaen Olasolo J, Alonso Redondo E, Exposito Hernandez J, de las Penas Cabrera MD, Cabrera Roldan P. Evidence-based estimation and radiotherapy utilisation rate in Andalusia. Clin Transl Oncol 2007;9:789-96. DOI |
15 | Barton MB, Jacob S, Shafiq J, et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother Oncol 2014;112:140-4. DOI |
16 | Mackillop WJ, Kong W, Brundage M, et al. A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario. Int J Radiat Oncol Biol Phys 2015;91:1099-107. DOI |
17 | Borras JM, Lievens Y, Dunscombe P, et al. The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis. Radiother Oncol 2015;116:38-44. DOI |
18 | Rosenblatt E, Barton M, Mackillop W, et al. Optimal radiotherapy utilisation rate in developing countries: an IAEA study. Radiother Oncol 2015;116:35-7. DOI |
![]() |